Neurology Clinical Trials
Upcoming Trials - Not Yet Enrolling:
Acute Ischemic Stroke - QUEST-KETA
- Quelling of Excitotoxicity in Acute Stroke with Ketamine (QUEST-KETA) trial will investigate the efficacy and side effects of IV Ketamine to reduce neuroexcitotoxicity, and thus provide neuroprotection in patients diagnosed with acute ischemic stroke.
- Will be enrolling early September 2017
- Coordinated by the Doylestown Health Medical Research Department: 215-345-2119
For more information about Doylestown Health's open trials visit the U.S. National Institutes of Health's Clinical Trials database.